News Search

Category: Schools

Penn Medicine’s Ben Black Shortlisted for Life Sciences Breakthrough of the Year Award from Falling Walls For his Research on Synthetic Human Chromosomes 

Ben Black was one the Winners in the Life Sciences category for Breakthrough of the Year Award from Falling Walls.

Penn Engineering’s Jacob Gardner Leverages AI to accelerate scientific research across disciplines

In an interview with Penn Today, Gardner explained his vision for creating AI-powered tools.

Penn’s Boon Loo Talks to Technical.ly Philly about his Experience in Academic Entrepreneurship   

Penn Engineering’s Boon Thau Loo, PhD, Senior Associate Dean for Education and Global Initiatives, was featured in Technical.ly Philly for his deep personal experiences with academic entrepreneurship.

Penn Leads NSF Sponsored AIRFoundry to Revolutionize RNA Research, Leveraging AI to Further Optimize and Innovate  

It is an $18-million initiative focused on advancing RNA research through AI-driven innovation and advanced manufacturing techniques.  

Penn spinout Linnaeus Therapeutics secures an additional $1.6M in Funding  

Penn spinout Linnaeus Therapeutics has raised another $1.6 million in financing, bringing its cumulative funding total to over $13 million since 2018.   

Penn Robotics Startup Sahay AI Aims to Make Railroads Safer  

Sahay AI is focused on transforming railway inspections through innovative AI-powered solutions.

Exyn Technologies and Stitch3D Announce Partnership; Exyn Advances AI Aerial Autonomy Technology to Overcome Dust in Underground Mines  

The goal of the collaboration is to to host, manage, view, process and share point cloud data securely directly on the web.  

iECURE included on list of Fierce Biotech’s 2024 Fierce 15  

iECURE was recognized for its innovative approach to treating rare childhood diseases by developing therapies that correct gene function directly inside the body.

Penn Spinout Interius BioTherapeutics Raises Additional $67M and doses first patient

The company’s approach focuses on creating cancer-fighting cells directly inside the body, potentially bypassing the need for external cell manipulation and chemotherapy.

Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases   

Carisma has expanded its collaboration with Moderna to develop two chimeric antigen receptor macrophage (CAR-M) targets for autoimmune disease treatment. 

Filter